X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
middle aged (10) 10
female (9) 9
hematology (9) 9
male (8) 8
adult (7) 7
index medicus (7) 7
chemotherapy (6) 6
oncology (6) 6
aged (5) 5
medicine & public health (5) 5
treatment outcome (5) 5
cancer (4) 4
disease (4) 4
lymphomas (4) 4
stem cells (4) 4
1st-line treatment (3) 3
adolescent (3) 3
aged, 80 and over (3) 3
analysis (3) 3
central nervous system neoplasms - mortality (3) 3
central-nervous-system (3) 3
follow-up studies (3) 3
hematopoietic stem cell transplantation - adverse effects (3) 3
prognosis (3) 3
transplantation (3) 3
young adult (3) 3
acute disease (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bone-marrow-transplantation (2) 2
central nervous system neoplasms - radiotherapy (2) 2
diagnosis (2) 2
disease-free survival (2) 2
dose-response relationship, drug (2) 2
germany (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cell transplantation (2) 2
hematopoietic stem cells (2) 2
induction chemotherapy - methods (2) 2
journal article (2) 2
kaplan-meier estimate (2) 2
leukemia, myeloid, acute - drug therapy (2) 2
lymphoma - mortality (2) 2
lymphoma - radiotherapy (2) 2
medicine (2) 2
methotrexate (2) 2
methotrexate - administration & dosage (2) 2
methotrexate - adverse effects (2) 2
mortality (2) 2
mutations (2) 2
original (2) 2
progression-free survival (2) 2
prospective studies (2) 2
radiotherapy (2) 2
response criteria (2) 2
survival (2) 2
usage (2) 2
versus-host-disease (2) 2
whole-brain radiotherapy (2) 2
1st relapse (1) 1
610 medicine & health (1) 1
abridged index medicus (1) 1
acute kidney injury - chemically induced (1) 1
acute myeloid leukaemia (1) 1
acute myeloid leukemia (1) 1
adaptation, psychological (1) 1
adult patients (1) 1
age (1) 1
age factors (1) 1
all- trans retinoic acid (1) 1
all-trans retinoic acid (1) 1
alleles (1) 1
allogeneic stem cell transplantation (1) 1
anemia - chemically induced (1) 1
anemia, refractory, with excess of blasts - complications (1) 1
anemia, refractory, with excess of blasts - therapy (1) 1
anticoagulants (1) 1
antimetabolites, antineoplastic - administration & dosage (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
arsenic trioxide (1) 1
bcl-2 (1) 1
benzamides - administration & dosage (1) 1
biometry (1) 1
blasts (1) 1
blood (1) 1
blood platelets - chemistry (1) 1
bone marrow (1) 1
bone marrow transplantation (1) 1
bone marrow transplantation - psychology (1) 1
brentuximab vedotin (1) 1
cancer progression (1) 1
cancer survival (1) 1
cancer therapies (1) 1
cancer-related fatigue (1) 1
capillary electrophoresis (1) 1
capillary-electrophoresis (1) 1
care and treatment (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1036 - 1047
Summary Background High-dose methotrexate is the standard of care for patients with newly diagnosed primary CNS lymphoma. The role of whole brain radiotherapy... 
Hematology, Oncology and Palliative Medicine | DEFERRED RADIOTHERAPY | 1ST-LINE TREATMENT | ONCOLOGY-GROUP | COMBINED-MODALITY THERAPY | ONCOLOGY | CONSOLIDATION RADIOTHERAPY | CELL TRANSPLANTATION | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | CHEMOTHERAPY | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Lymphoma - mortality | Antimetabolites, Antineoplastic - administration & dosage | Central Nervous System Neoplasms - radiotherapy | Lymphoma - drug therapy | Time Factors | Dose Fractionation | Female | Lymphoma - radiotherapy | Radiotherapy, Adjuvant | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Chi-Square Distribution | Cranial Irradiation - adverse effects | Cytarabine - administration & dosage | Disease-Free Survival | Methotrexate - adverse effects | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Methotrexate - administration & dosage | Aged | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Germany | Chemotherapy | Radiation | Product development | Lymphomas | Methotrexate | Radiotherapy | Biometry | Cancer
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 12/2016, Volume 95, Issue 12, pp. 1931 - 1942
Journal Article
Annals of Hematology, ISSN 0939-5555, 3/2015, Volume 94, Issue 3, pp. 409 - 414
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 7/2014, Volume 93, Issue 7, pp. 1167 - 1176
Journal Article
Journal Article
Journal Article